Back

Medication persistence and mortality in SWEDEHEART STEMI patients with and without standard modifiable risk factors

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Late-Breaking Clinical Science: coronary risk and outcomes Pharmacotherapy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Ms Suzanne Robyn Avis

University of Sydney, Sydney (Australia)

3 More presentations in this session

Presentation thumbnail
Cardiovascular risk in patients classified according to the Universal Definition of Myocardial Infarction
Doctor A. Chapman (Edinburgh, GB)
Slides Video
Presentation thumbnail
Monitoring treatment of myocardial infarction in Europe – EuroHeart Annual report 2025
Professor D. Erlinge (Lund, SE)
Slides Video
Presentation thumbnail
Kidney function and coronary artery disease
Professor L. Ryden (Stockholm, SE)
Slides Video

Access the full session

Session thumbnail
Late-Breaking Clinical Science: coronary risk and outcomes
Video

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Patients without conventional modifiable risk factors (SMuRFless) presenting with obstructive myocardial infarction face a significantly higher 30-day mortality
thumbnail
Congress Presentation
Prevalence and outcomes of acute coronary syndrome patients with and without standard modifiable risk factors undergoing percutaneous coronary intervention
thumbnail
Congress Presentation
Standard modifiable risk factors and mortality in patients with ST-segment elevation myocardial infarction: findings from the FRENCHIE cohort.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources